Correlation of nitric oxide levels in the cerebellum and spinal cord of experimental autoimmune encephalomyelitis rats with clinical symptoms

Acta Neurobiologiae Experimentalis

Volumn 72, Issue 1, 2012, Pages 33-39

  Ljubisavljevic, Srdjan ^a   Stojanovic, Ivana ^a   Pavlovic, Dusica ^a   Milojkovic, Maja ^a   Vojinovic, Slobodan ^a   Sokolovic, Dusan ^a   Stevanovic, Ivana ^b  

^a UNIVERSITY OF NI   (Serbia)

^b UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

Experimental autoimmune encephalomyelitis; Nitric oxide

Indexed keywords

ACETYLCYSTEINE; FREUND ADJUVANT; MYELIN BASIC PROTEIN; NITRIC OXIDE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL; ARTICLE; CEREBELLUM; DISEASE MODEL; DRUG EFFECT; FEMALE; IMMUNOLOGY; METABOLISM; RAT; SPINAL CORD; SPRAGUE DAWLEY RAT;

ACETYLCYSTEINE; ANIMALS; CEREBELLUM; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FREUND'S ADJUVANT; MYELIN BASIC PROTEIN; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD;

EID: 84859940328     PISSN: 00651400     EISSN: 16890035     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Beckman JS, Chen J, Crow JP, Ye YZ (1994) Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegeneration. Prog Brain Res 103: 371-380.
2. Beckman JS, Koppenol WH (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271: C1424-C37.
3. Bishop A, Hobbs K, Eguchi A, Jeffrey S, Smallwood L, Pennie C, Anderson J, Estevez A (2009) Differential sensitivity of oligodendrocytes and motor neurons to reactive nitrogen species: implications for multiple sclerosis. J Neurochem 109: 93-104.
4. Blanco S, Molina FJ, Castro L, Del Moral ML, Hernandez R, Jimenez A, Alma Rus A, Martinez-Lara E, Siles E, Peinado MA (2010) Study of the nitric oxide system in the rat cerebellum during aging. BMC Neurosci 11: 78.
5. Bo L, Dawson TM, Wesselingh S, Mork S, Choi S, Kong PA, Hanley D, Trapp BD (1994) Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 36: 778-786.
6. Boullerne AI, Petry KG, Meynard M, Geffard M (1995) Indirect evidence for nitric oxide involvement in multiple sclerosis by characterization of circulating antibodies directed against conjugated S-nitrosocysteine. J Neuroimmunol 60: 117-124.
7. Brenner T, Brocke S, Szafer F, Sobel RA, Parkinson JF, Perez DH, Steinman L (1997) Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. J Immunol 158: 2940-2946.
8. Brown G, Bal-Price AM (2003) Inflammatory neurodegeneration mediated by nitric oxide, glutamate and mitochondria. Mol Neurobiol 27: 325-355.
9. Buchwalow IB (2001) Increasing the power of immunohistochemistry. Proc Roy Microsc Soc 36: 57-59.
10. Calabrese V, Scapagnini G, Ravagna A, Bella R, Foresti R, Bates TE, Giuffrida Stella AM, Pennisi G (2002) Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels. J Neurosci Res 70: 580-587.
11. Cross AH, Manning PT, Keeling RM, Schmidt RE, Misko TP (1998) Peroxynitrite formation within the central nervous system in active multiple sclerosis. J Neuroimmunol 88: 45-56.
12. De Groot CJ, Ruuls SR, Theeuwes JW, Dijkstra CD, Van Der Valk P (1997) Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J Neuropathol Exp Neurol 56: 10-20.
13. Farias AS, de la Hoz C, Castro FR, Oliveira EC, Ribeiro dos Reis JR, Silva JS, Langone F, Santos LM (2007) Nitric oxide and TNFa effects in experimental autoimmune encephalomyelitis demyelination. Neuroimmunomodulation 14: 32-38.
14. Fenyk-Melody JE, Garrison AE, Brunnert SR, Weidner JR, Shen F, Shelton BA, Mudgett JS (1998) Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J Immunol 160: 2940-2946.
15. Henderson A, Barnett M, Parratt J, Prineas J (2009) Multiple sclerosis: Distribution of inflammatory cells in newly forming lesions. Ann Neurol 66: 739-753.
16. Jack C, Ruffini F, Bar-Or A, Antel JP (2005) Microglia and multiple sclerosis. J Neurosci Res 81: 363-373.
17. Kahl KG, Zielasek J, Uttenthal LO, Rodrigo J, Toyka KV, Schmidt HH (2003) Protective role of the cytokine-inducible isoform of nitric oxide synthase induction and nitrosative stress in experimental autoimmune encephalomyelitis of the DA rat. J Neurosci Res 73: 198-205.
18. Kim JH, Budde MD, Liang HF, Klein RS, Russell JH, Cross AH, Song SK (2006) Detecting axon damage in spinal cord from a mouse model of multiple sclerosis. Neurobiol Dis 21: 626-632.
19. Knowles RG, Moncada S (1994) Nitric oxide synthases in mammals. Biochem J 298: 249-248.
20. Kornek B, Storch MK, Weissert R, Wallstroem E, Stefferl A, Olsson T, Linington C, Schmidbauer M, Lassmann H (2000) Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 157: 267-276.
21. Lin RF, Lin TS, Tilton RG, Cross AH (1993) Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic resonance study. J Exp Med 178: 643-648.
22. Ljubisavljevic S, Stojanovic I, Pavlovic D, Sokolovic D, Stevanovic I (2011) Aminoguanidine and N-Acetyl-Cysteine supress oxidative and nitrosative stress in EAE rat brains. Redox Rep 16: 166-172.
23. Losy J, Niezgoda A, Wender M (1999) Increased serum levels of soluble PECAM-1 in multiple sclerosis patients with brain gadoliniumenhancing lesions. J Neuroimmunol 99: 169-172.
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193: 265-275.
25. Malabendu J, Kalipada P (2005) Redox regulation of cytokine-mediated inhibition of myelin gene expression in human primary oligodendrocytes. Free Radic Biol Med 39: 823-831.
26. Marques C, Cheeran M, Palmquist J, Hu S, Lokensgard J (2008) Microglia are the major cellular source of inducible nitric oxide synthase during experimental herpes encephalitis. J Neurovirol 14: 229-238.
27. Mitrovic B, Ignarro LJ, Montestruque S, Smoll A, Merrill JE (1994) Nitric oxide as a potential pathological mechanism in demyelination: Its differential effects on primary glial cells in vitro. Neuroscience 61: 575-585.
28. Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142.
29. Muzhou WU, Tsirka SE (2009) Endothelial NOS-deficient mice reveal dual roles for nitric oxide during experimental autoimmune encephalomyelitis. Glia 57: 1204-1215.
30. Napoli I, Neumann H (2010) Protective effects of microglia in multiple sclerosis. Exp Neurol 225: 24-28.
31. Nathan C, Xie QW (1994) Nitric oxide synthase: roles, tolls and control. Cell 78: 919.
32. Navaro-Gonzalvez JA, Garcia-Benayas C, Arenas J (1998) Semiautomated measurement of nitrate in biological fluids. Clin Chem 44: 679-681.
33. Okuda Y, Sakoda S, Fujimura H, Yanagihara T (1997) Nitric oxide via an inducible isoform of nitric oxide synthase is a possible factor to eliminate cells from the central nervous system of mice with experimental allergic encephalomyelitis. J. Neuroimmunol 73: 107.
34. Okuda Y, Sakoda S, Fujimura H, Yanagihara T (1998) Aminoguanidine, a selective inhibitor of the inducible nitric oxide synthase, has different effects on experimental allergic encephalomyelitis in the induction and progression phase. J Neuroimmunol 81: 201-210.
35. Pahan K, Sheikh FG, Namboodiri AM, Singh I (1998) N-acetyl cysteine inhibits induction of NO production by endotoxin or cytokine stimulated rat peritoneal macrophages, C6 glial cells and astrocytes. Free Radic Biol Med 24: 39-48.
36. Pautz A, Art J, Hahn S, Nowag S, Voss C, Kleinert H (2010) Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide 23: 75-93.
37. Raine CS, Barnett LA, Brown A, McFarlin DE (1980) Neuropathology of experimental allergic encephalomyelitis in bred strains of mice. Lab Invest 43: 150.
38. Ruuls SR, Van der Linden S, Sontrop K, Huitinga I, Dijkstra CD (1996) Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clin Exp Immunol 103: 467-474.
39. Saito S, Kidd GJ, Trapp BD, Dawson TM, Bredt DS, Wilson DA, Traystman RJ, Snyder SH, Hanley DF (1994) Rat spinal cord neurons contain nitric oxide synthase. Neuroscience 59: 447-456.
40. Sajad M, Zargan J, Chawla R, Umar S, Sadaqat M, Khan H (2009) Hippocampal neurodegeneration in experimental autoimmune encephalomyelitis (EAE): potential role of inflammation activated myeloperoxidase. Mol Cell Biochem 328: 183-188.
41. Smith KJ, Kapoor R, Paul A (1999) Demyelination: The role of reactive oxygen and nitrogen species. Brain Pathol 9: 69-92.
42. Thiel VE, Audus KL (2001) Nitric oxide and blood-brain barrier integrity. Antioxid Redox Signal 3: 273-78.
43. Willenborg DO, Staykova MA (1998) Approaches to the treatment of central nervous system autoimmune disease using specific neuroantigen. Immunol Cell Biol 76: 91.
44. Xu LY, Yang JS, Link H, Xiao BG (2001) SIN-1, a nitric oxide donor, ameliorates experimental allergic encephalomyelitis in Lewis rats in the incipient phase: the importance of the time window. J Immunol 166: 5810-5816.
45. Yamashita T, Ando Y, Obayashi K, Uchino M, Ando M (1997) Changes in nitrite and nitrate (NO2/-/NO3/-) levels in cerebrospinal fluid of patients with multiple sclerosis. J Neurol Sci 153: 32-34.